EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Identification of impactful imaging biomarker: Clinical applications for breast and prostate carcinoma

Tobias Bäuerle, Matthias Dietzel iD, Katja Pinker, David Bonekamp, Kevin S Zhang, Heinz-Peter Schlemmer, Peter Bannas, Clemens C Cyran, Michel Eisenblätter, Ingrid Hilger, Caroline Jung, Fritz Schick und 2 weitere

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.04.2024 · 196 (04) · 354-362

DOI: 10.1055/a-2175-4446 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.04.2024. Verfasst von Tobias Bäuerle und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Radiology, University Medical Center Erlangen, Germany. Hauptthemen laut MEDLINE: Carcinoma, Nuclear Medicine, Prostatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Imaging biomarkers are quantitative parameters from imaging modalities, which are collected noninvasively, allow conclusions about physiological and pathophysiological processes, and may consist of single (monoparametric) or multiple parameters (bi- or multiparametric).

Method

This review aims to present the state of the art for the quantification of multimodal and multiparametric imaging biomarkers. Here, the use of biomarkers using artificial intelligence will be addressed and the clinical application of imaging biomarkers in breast and prostate cancers will be explained. For the preparation of the review article, an extensive literature search was performed based on Pubmed, Web of Science and Google Scholar. The results were evaluated and discussed for consistency and generality. Results and Conclusion Different imaging biomarkers (multiparametric) are quantified based on the use of complementary imaging modalities (multimodal) from radiology, nuclear medicine, or hybrid imaging. From these techniques, parameters are determined at the morphological (e. g., size), functional (e. g., vascularization or diffusion), metabolic (e. g., glucose metabolism), or molecular (e. g., expression of prostate specific membrane antigen, PSMA) level. The integration and weighting of imaging biomarkers are increasingly being performed with artificial intelligence, using machine learning algorithms. In this way, the clinical application of imaging biomarkers is increasing, as illustrated by the diagnosis of breast and prostate cancers. Key Points Citation Format

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinomaNuclear MedicineProstatic NeoplasmsHumansMaleArtificial IntelligenceBiomarkersMagnetic Resonance ImagingProstateFemale

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Institute of Radiology, University Medical Center Erlangen, Germany.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, United States.
  • Department of Radiology, German Cancer Research Center, Heidelberg, Germany.
  • Institute of Diagnostic and Interventional Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Institute of Radiology, University Medical Center München (LMU), München, Germany.
  • Diagnostische und Interventionelle Radiologie, Universitätsklinikum OWL, Universität Bielefeld Campus Klinikum Lippe, 32756 Detmold, Germany.

ORCID-Profile: Matthias Dietzel, Fabian Kiessling

Zitieren

APA

Bäuerle, T., Dietzel, M., Pinker, K., Bonekamp, D., Zhang, K. S., Schlemmer, H. P., Bannas, P., Cyran, C. C., Eisenblätter, M., Hilger, I., Jung, C., Schick, F., Wegner, F., & Kiessling, F. (2024). Identification of impactful imaging biomarker: Clinical applications for breast and prostate carcinoma. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 196(04), 354-362. https://doi.org/10.1055/a-2175-4446

Vancouver

Bäuerle T, Dietzel M, Pinker K, Bonekamp D, Zhang KS, Schlemmer HP, et al. Identification of impactful imaging biomarker: Clinical applications for breast and prostate carcinoma. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2024;196(04):354-362. doi:10.1055/a-2175-4446

BibTeX
@article{Buerle2024,
  author = {Bäuerle, Tobias and Dietzel, Matthias and Pinker, Katja and Bonekamp, David and Zhang, Kevin S and Schlemmer, Heinz-Peter and Bannas, Peter and Cyran, Clemens C and Eisenblätter, Michel and Hilger, Ingrid and Jung, Caroline and Schick, Fritz and Wegner, Franz and Kiessling, Fabian},
  title = {Identification of impactful imaging biomarker: Clinical applications for breast and prostate carcinoma},
  journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
  year = {2024},
  volume = {196},
  number = {04},
  pages = {354--362},
  doi = {10.1055/a-2175-4446}
}
Kostenlos starten →